Topic
Uterine artery embolization
💡 What You Need to Know
- Minimally Invasive Procedure: Uterine artery embolization (UAE) is a non-surgical, image-guided procedure performed by an interventional radiologist.
- Target Condition: Primarily used to treat symptomatic uterine fibroids (leiomyomas) and, less commonly, adenomyosis.
- Mechanism of Action: Involves blocking the blood supply to the uterus and fibroids by injecting embolic agents into the uterine arteries, causing the fibroids to shrink.
- Symptom Relief: Aims to alleviate heavy menstrual bleeding, pelvic pain, pressure, and other symptoms caused by fibroids.
- Uterus Preservation: Offers an alternative to hysterectomy (removal of the uterus) or myomectomy (surgical removal of fibroids) for women who wish to preserve their uterus.
🤒 Associated Symptoms
- Heavy Menstrual Bleeding (Menorrhagia): Prolonged or excessively heavy periods leading to anemia.
- Pelvic Pain and Pressure: Chronic discomfort, bloating, or a feeling of fullness in the lower abdomen.
- Frequent Urination: Due to fibroids pressing on the bladder.
- Constipation: Resulting from fibroids pressing on the rectum.
- Dyspareunia: Pain or discomfort during sexual intercourse.
- Back and Leg Pain: If fibroids press on nerves in the pelvis.
- Abdominal Enlargement: Visible distension of the abdomen in some cases.
🛡 Crucial Precautions
- Pregnancy Status: UAE is contraindicated in pregnant individuals; a pregnancy test is mandatory prior to the procedure.
- Allergy to Contrast Dye: Inform the medical team of any known allergies to iodine-based contrast agents.
- Renal Function Assessment: Kidney function must be evaluated (e.g., creatinine levels) due to the use of contrast dye.
- Anticoagulant Medications: Discontinue blood-thinning medications (e.g., warfarin, aspirin, NSAIDs) as advised by the physician, typically several days before the procedure.
- Active Infection: The procedure is contraindicated in the presence of active pelvic infection.
- Malignancy Exclusion: Ensure that symptoms are not due to a suspected uterine malignancy, as UAE is not appropriate for cancerous conditions.
🍽 Dietary Directions & Restrictions
- Pre-Procedure Fasting: Typically, no food or drink (NPO) for 6-8 hours prior to the procedure to prevent aspiration during sedation.
- Hydration: Maintain adequate hydration in the days leading up to the procedure, unless otherwise instructed.
- Post-Procedure Nausea Management: Start with clear liquids and light, bland foods after the procedure, especially if experiencing nausea from anesthesia or pain medication.
- Avoid Irritants: Refrain from consuming heavy, fatty, spicy, or acidic foods immediately post-procedure to minimize gastrointestinal upset.
- Medication with Food: Take prescribed pain medications or anti-nausea drugs with a small amount of food to reduce stomach irritation, if permitted.
⚠️ Attendant Guidelines
- Post-Procedure Monitoring: Expect to remain in the hospital for observation, typically overnight, to monitor for complications and manage post-embolization syndrome.
- Pain Management: Significant pelvic pain and cramping are common post-procedure; adhere strictly to prescribed pain medication regimens.
- Signs of Complication: Immediately report severe, unmanageable pain, high fever (above 100.4°F or 38°C), foul-smelling vaginal discharge, or persistent heavy bleeding.
- Activity Restrictions: Avoid strenuous activities, heavy lifting, and vaginal intercourse for several weeks as advised by your physician.
- Responsible Adult Escort: Arrange for a responsible adult to drive you home after discharge and assist with initial recovery, as you will be recovering from sedation.
- Follow-up Appointments: Adhere to all scheduled follow-up appointments for clinical assessment and imaging to monitor fibroid shrinkage and symptom improvement.
🩺 Physician's Perspective
- Patient Selection: UAE is a highly effective treatment for carefully selected patients with symptomatic uterine fibroids who desire a less invasive option than surgery.
- Pre-Procedure Evaluation: A comprehensive gynecological evaluation, including imaging (MRI or ultrasound), is crucial to confirm the diagnosis, assess fibroid characteristics, and rule out malignancy.
- Fertility Considerations: While many women have successful pregnancies after UAE, it is important to discuss potential impacts on fertility and pregnancy outcomes with patients, especially those planning future pregnancies.
- Post-Embolization Syndrome: Educate patients thoroughly about the expected post-embolization syndrome (pain, fever, nausea, malaise) and provide robust pain management strategies.
- Long-Term Outcomes: Emphasize the high success rates in symptom improvement, but also discuss the possibility of fibroid recurrence or the need for further intervention in a small percentage of cases.
- Multidisciplinary Approach: Often involves collaboration between gynecologists and interventional radiologists to ensure optimal patient care and outcomes.
🎓 Academic & Nursing Corner
- Pre-Procedure Assessment: Conduct thorough patient history, vital signs, allergy assessment (especially contrast), and confirm NPO status. Ensure informed consent is signed.
- IV Access and Sedation Monitoring: Establish reliable IV access and monitor patient during conscious sedation, assessing respiratory status, oxygen saturation, and cardiac rhythm.
- Post-Procedure Pain Management: Administer analgesics as prescribed, assess pain levels frequently, and utilize non-pharmacological comfort measures.
- Monitoring for Complications: Closely monitor for signs of bleeding at the femoral access site, neurovascular compromise in the affected leg, and symptoms of infection (fever, chills, purulent discharge).
- Post-Embolization Syndrome Care: Educate patient on expected symptoms (pain, fever, nausea) and provide antiemetics and antipyretics as needed.
- Discharge Education: Provide clear instructions on activity restrictions, wound care, medication schedule, signs of complications to report, and follow-up appointments.
🔬 Clinical Reference Index
- CPT Codes: Common codes include 37243 (Embolization, uterine artery, for fibroids).
- Embolic Agents: Polyvinyl alcohol (PVA) particles, tris-acryl gelatin microspheres (e.g., Embosphere, Bead Block), gelatin sponge.
- Imaging Modalities: Pre-procedure: Pelvic MRI with and without contrast, transvaginal ultrasound. Post-procedure: Follow-up MRI or ultrasound to assess fibroid volume reduction.
- Common Complications: Post-embolization syndrome (pain, fever, nausea, malaise), infection, uterine necrosis, non-target embolization, ovarian dysfunction, amenorrhea.
- Indications: Symptomatic uterine leiomyomas (fibroids), adenomyosis (off-label, less common).
- Contraindications: Pregnancy, active pelvic infection, suspected uterine malignancy, severe renal insufficiency, allergy to contrast media, severe peripheral vascular disease precluding arterial access.